Recruiting Pulmonary Embolism Studies in Arkansas City
About Pulmonary Embolism Clinical Trials in Arkansas City
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 1 pulmonary embolism clinical trials recruiting participants in Arkansas City, AR. These studies are seeking a combined 70 participants. Research is being sponsored by UroGen Pharma Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Arkansas City — FAQ
Are there pulmonary embolism clinical trials in Arkansas City?
Yes, there are 1 pulmonary embolism clinical trials currently recruiting in Arkansas City, AR. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Arkansas City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Arkansas City research site will contact you about next steps.
Are clinical trials in Arkansas City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Arkansas City studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 1 active trials in Arkansas City are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated October 12, 2026 from ClinicalTrials.gov